Kissei Pharmaceutical Co., Ltd. (TYO:4547)
Japan · Delayed Price · Currency is JPY 3,815.00
0.00 (0.00%)
Oct 23, 2026, 3:30 PM JST
Kissei Pharmaceutical Financials Overview
Financials in millions JPY. Fiscal year is April - March.
Millions JPY. Fiscal year is Apr - Mar.
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Revenue Revenue Growth | 98,604 | 97,406 | 88,330 | 75,579 | 67,493 | 65,381 |
Revenue Growth | 10.35% | 10.27% | 16.87% | 11.98% | 3.23% | -5.30% |
Gross Profit Gross Profit Growth | 46,172 | 45,819 | 44,065 | 37,341 | 32,375 | 31,238 |
Operating Income Operating Income Growth | -3,939 | -2,926 | 5,774 | 4,017 | -1,143 | -1,402 |
Net Income Net Income Growth | 13,983 | 13,779 | 11,961 | 11,160 | 10,528 | 12,921 |
Earnings Per Share EPS Growth | 337.33 | 331.53 | 274.20 | 246.58 | 228.30 | 280.19 |
EPS Growth | 17.34% | 20.91% | 11.20% | 8.01% | -18.52% | 147.41% |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Elimination of Inter-Segment Transactions Elimination of Inter-Segment Transactions Growth | -6,095 | -6,288 | -5,418 | -4,179 | -3,192 | -3,424 |
Goods Sales Goods Sales Growth | 1,113 | 1,137 | 1,068 | 983 | 824 | 763 |
Construction and Facility Maintenance Construction and Facility Maintenance Growth | 6,870 | 7,381 | 5,985 | 4,915 | 3,275 | 4,331 |
Pharmaceuticals Pharmaceuticals Growth | 78,733 | 77,950 | 75,299 | 63,348 | 56,243 | 54,147 |
Information Service Information Service Growth | 17,981 | 17,225 | 11,395 | 10,511 | 10,342 | 9,562 |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Cash & Investments Cash & Investments Growth | 52,954 | 54,424 | 48,654 | 45,933 | 49,599 | 53,152 |
Total Debt Total Debt Growth | 1,250 | 1,250 | 1,280 | 1,340 | 1,490 | 1,640 |
Net Cash (Debt) Net Cash Growth | 51,704 | 53,174 | 47,374 | 44,593 | 48,109 | 51,512 |
Net Cash Growth | 8.91% | 12.24% | 6.24% | -7.31% | -6.61% | 20.61% |
Net Cash Per Share Net Cash Per Share Growth | 1247.32 | 1279.38 | 1086.01 | 985.30 | 1043.24 | 1117.03 |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Operating Cash Flow Operating Cash Flow Growth | - | -1,485 | 6,521 | -1,677 | -6,679 | 1,533 |
Capital Expenditures CapEx Growth | - | -4,883 | -4,507 | -1,201 | -2,103 | -1,489 |
Free Cash Flow Free Cash Flow Growth | - | -6,368 | 2,014 | -2,878 | -8,782 | 44 |
Free Cash Flow Growth | - | - | - | - | - | - |
Fiscal Year | TTM | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Gross Margin | 46.83% | 47.04% | 49.89% | 49.41% | 47.97% | 47.78% |
Operating Margin | -4.00% | -3.00% | 6.54% | 5.32% | -1.69% | -2.14% |
Pretax Margin | 17.68% | 17.34% | 17.67% | 19.12% | 20.27% | 25.25% |
Profit Margin | 14.18% | 14.15% | 13.54% | 14.77% | 15.60% | 19.76% |
FCF Margin | - | -6.54% | 2.28% | -3.81% | -13.01% | 0.07% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Dividend Per Share Dividend Per Share Growth | 130.000 | 120.000 | 100.000 | 82.000 | 80.000 | 56.000 |
Dividend Per Share Growth | 78.26% | 20.00% | 21.95% | 2.50% | 42.86% | 3.70% |
Dividend Yield | 3.41% | 2.58% | 2.60% | 2.32% | 3.03% | 2.19% |
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 25, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 11.31 | 13.99 | 13.76 | 14.00 | 11.57 | 9.12 |
Forward PE | 14.32 | 15.06 | 17.88 | 14.26 | 10.90 | 36.67 |
P/FCF Ratio | - | - | 81.72 | - | - | 2677.87 |
PS Ratio | 1.60 | 1.98 | 1.86 | 2.07 | 1.81 | 1.80 |